295 related articles for article (PubMed ID: 30450621)
21. Sample size re-estimation for adaptive sequential design in clinical trials.
Gao P; Ware JH; Mehta C
J Biopharm Stat; 2008; 18(6):1184-96. PubMed ID: 18991116
[TBL] [Abstract][Full Text] [Related]
22. Stepwise two-stage sample size adaptation.
Wan H; Ellenberg SS; Anderson KM
Stat Med; 2015 Jan; 34(1):27-38. PubMed ID: 25252082
[TBL] [Abstract][Full Text] [Related]
23. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
Jahn-Eimermacher A; Hommel G
Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
[TBL] [Abstract][Full Text] [Related]
24. Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group.
Gallo P; Chuang-Stein C; Dragalin V; Gaydos B; Krams M; Pinheiro J;
J Biopharm Stat; 2006 May; 16(3):275-83; discussion 285-91, 293-8, 311-2. PubMed ID: 16724485
[TBL] [Abstract][Full Text] [Related]
25. Two-stage designs for cross-over bioequivalence trials.
Kieser M; Rauch G
Stat Med; 2015 Jul; 34(16):2403-16. PubMed ID: 25809815
[TBL] [Abstract][Full Text] [Related]
26. An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials.
Mi MY; Betensky RA
Clin Trials; 2013 Apr; 10(2):207-15. PubMed ID: 23283576
[TBL] [Abstract][Full Text] [Related]
27. Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size.
Mauer M; Collette L; Bogaerts J;
Eur J Cancer; 2012 Jun; 48(9):1386-91. PubMed ID: 22281098
[TBL] [Abstract][Full Text] [Related]
28. Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event Outcomes.
Ryeznik Y; Sverdlov O; Hooker AC
AAPS J; 2017 Dec; 20(1):24. PubMed ID: 29285730
[TBL] [Abstract][Full Text] [Related]
29. Group sequential and discretized sample size re-estimation designs: a comparison of flexibility.
Wu X; Cui L
Stat Med; 2012 Oct; 31(24):2844-57. PubMed ID: 22733405
[TBL] [Abstract][Full Text] [Related]
30. Minimax and admissible adaptive two-stage designs in phase II clinical trials.
Shan G; Zhang H; Jiang T
BMC Med Res Methodol; 2016 Aug; 16():90. PubMed ID: 27485595
[TBL] [Abstract][Full Text] [Related]
31. Paradigms for adaptive statistical information designs: practical experiences and strategies.
Wang SJ; Hung HM; O'Neill R
Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
[TBL] [Abstract][Full Text] [Related]
32. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
[TBL] [Abstract][Full Text] [Related]
33. Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.
Wassmer G
J Biopharm Stat; 2003 Nov; 13(4):585-603. PubMed ID: 14584710
[TBL] [Abstract][Full Text] [Related]
34. Benefits, challenges and obstacles of adaptive clinical trial designs.
Chow SC; Corey R
Orphanet J Rare Dis; 2011 Nov; 6():79. PubMed ID: 22129361
[TBL] [Abstract][Full Text] [Related]
35. Vasopressors and the search for the optimal trial design.
Maharaj R
Contemp Clin Trials; 2011 Nov; 32(6):924-30. PubMed ID: 21807122
[TBL] [Abstract][Full Text] [Related]
36. A group sequential, response-adaptive design for randomized clinical trials.
Karrison TG; Huo D; Chappell R
Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
[TBL] [Abstract][Full Text] [Related]
37. Group sequential, sample size re-estimation and two-stage adaptive designs in clinical trials: a comparison.
Shih WJ
Stat Med; 2006 Mar; 25(6):933-41. PubMed ID: 16220505
[No Abstract] [Full Text] [Related]
38. Issues in the use of adaptive clinical trial designs.
Emerson SS
Stat Med; 2006 Oct; 25(19):3270-96; discussion 3302-4, 3320-5, 3326-47. PubMed ID: 16906553
[TBL] [Abstract][Full Text] [Related]
39. On sample size and inference for two-stage adaptive designs.
Liu Q; Chi GY
Biometrics; 2001 Mar; 57(1):172-7. PubMed ID: 11252594
[TBL] [Abstract][Full Text] [Related]
40. Information-based sample size re-estimation in group sequential design for longitudinal trials.
Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
